PHD-2-siRNA-G-5-FA

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NamePHD-2-siRNA-G-5-FA
Drug Alias NamePHD2-siRNA-G5-FAPHD-2-siRNA-G-5-FA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProlyl hydroxylase domain-containing protein 2 inhibitors
TargetsProlyl hydroxylase domain-containing protein 2
Therapy Area/IndicationsAcute Kidney Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirginia Commonwealth University
China Registration ClassN/A

Develop Information

Active CompaniesVirginia Commonwealth University
Inactive CompaniesN/A
Active IndicationsAcute Kidney Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A